Researchers at the University of Georgia and Sanofi Pasteur, the vaccines division of Sanofi, announced today the development of a vaccine that protects against multiple strains of both seasonal and pandemic H1N1 influenza in mouse models.
They published their findings recently in the Journal of Virology.
Researchers from UGA and Sanofi Pasteur, which has a research and development collaboration agreement with UGA, will present their data tomorrow, March 30, at the World Vaccine Congress US 2016 in Washington, D.C.
“One of the problems with current influenza vaccines is that we have to make predictions about which virus strains will be most prevalent every year and build our vaccines around those predictions,” said Ted Ross, director of UGA’s Center for Vaccines and Immunology and Georgia Research Alliance Eminent Scholar in Infectious Diseases in the College of Veterinary Medicine. “What we have developed is a vaccine that protects against multiple different strains of H1N1 virus at once, so we might be able to one day replace the current standard of care with this more broadly cross-protective vaccine.”
The H1N1 influenza virus caused a worldwide pandemic in 2009. When it was first detected, it was called swine flu because the virus was similar to those found in pigs, but the virus now circulates as a seasonal form of influenza.
Using a technique called Computationally Optimized Broadly Reactive Antigen, or COBRA, UGA researchers Donald Carter, Christopher Darby and Bradford Lefoley, along with Ross, created nine prototype synthetic compound vaccines constructed using genetic sequences from multiple influenza virus strains.
The COBRA vaccines were designed to recognize H1N1 viruses isolated within the last 100 years, but many of the experimental vaccines produced immunity against influenza strains not included in the design. This means that scientists may be able to produce a vaccine that not only protects against recognized seasonal and pandemic influenza strains, but also strains that have yet to be discovered.
Because this vaccine is generated from the genetic sequences of multiple flu viruses, it may protect against many strains over several years, Ross said. That would also allow for year-round manufacturing of the vaccine, since scientists would not have to halt production every year to identify the most prevalent strains.
This research is part of a broader effort to create a universal influenza vaccine, which would protect against all strains of the virus.
“We still have some work to do before we get a truly universal flu vaccine,” Ross said. “But the COBRA vaccine we’ve developed for H1N1 virus subtypes is a major step in the right direction.”
Learn more:Â UGA, Sanofi Pasteur develop new vaccine for H1N1 influenza
The Latest on: Flu vaccine
[google_news title=”” keyword=”flu vaccine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Flu vaccine
- Nationals being mindful with Ruiz in his return from influenzaon April 25, 2024 at 5:47 pm
Sidelined for 13 team games, Keibert Ruiz wanted to get back behind the plate. The starting catcher was wiped out, though. At the beginning of the Nationals' three-city West Coast road trip, Ruiz came ...
- Flu shot fatigue: influenza vaccination rates in R.I. continue to fall post-pandemicon April 25, 2024 at 2:30 am
Chalk it up to shot sickness, or maybe just an inflated sense of immunity. Either way, fewer Rhode Island adults rolled up their sleeves for a flu shot this year, though the state remains a national ...
- Massive amounts of H5N1 vaccine would be needed if there’s a bird flu pandemic. Can we make enough?on April 24, 2024 at 10:53 am
The first signs that H5N1 avian flu was starting to spread from person to person would trigger a race to produce massive amounts of vaccine.
- USDA tries to find how H5N1 avian influenza spread to dairy cowson April 24, 2024 at 4:20 am
Dairy cattle transported from Texas have been implicated in the spread of the H5N1, or bird flu, virus found in at least four of the seven states outside of Texas that have reported infections, ...
- RIPK3 inhibitor prevents lung damage in severe influenza infectionon April 23, 2024 at 5:00 pm
Severe influenza A virus (IAV) infections cause 650,000 deaths annually and available antiviral treatments show limited efficacy. The pathology of severe infections is associated with lung ...
- Influenza is considered the biggest pandemic threaton April 23, 2024 at 9:30 am
Influenza is viewed by infectious disease specialists as the pathogen with the highest pandemic potential, according to findings unveiled at a major global congress in Barcelona.
- Is There a Vaccine for H5N1 Influenza?on April 22, 2024 at 2:31 pm
On the heels of a multi-state outbreak of highly pathogenic avian influenza A (H5N1) in dairy cows, experts told MedPage Today that a trio of H5N1 vaccines for humans has already been developed and ...
- New study rates influenza as the top pandemic threat, here’s whyon April 21, 2024 at 6:50 am
Other highly ranked pathogens included "Disease X", and the viruses responsible for SARS, SARS-CoV-2, and Ebola.
- Avian Influenza In Cattle And A Person Prompts Health Advisory From CDCon April 16, 2024 at 1:32 pm
The highly pathogenic avian influenza virus H5N1 has been identified in cattle and one person who was in contact with infected cattle. The spread is being monitored.
- Hesitant about getting a flu vaccine this winter? Here is what you need to knowon April 16, 2024 at 9:22 am
The flu is one of the most unpleasant common illnesses, with symptoms such as aches, pains, chills, fever, and cough. Additional symptoms such as runny nose, vomiting, diarrhoea, fatigue, and sore ...
via Bing News